Healthcare Tech Outlook Names GATC Health as Top 10 Precision Medicine Solution Providers

GATC Health, an innovative technology company focused on whole genome testing and disruptive multiomics-based artificial intelligence, today announced that it has been recognized by Healthcare Tech Outlook as one of the “Top 10 Precision Medicine Solution Providers” in its October 2021 publication. This special edition highlights innovative companies utilizing individuals’ unique biological data (usually DNA) to identify specific health risks and possible treatments.

In addition to recognizing GATC Health’s achievements in the field of precision medicine, Healthcare Tech Outlook’s editors interviewed Jeff Moses, the company’s president and chief marketing officer.

Excerpted from the article “GATC Health: Accurate, Personalized, and Predictive Insights into Human Biology”:

“The healthcare industry is on a constant pursuit to provide more accurate, precise, proactive, and impactful care for each individual patient. Advances in biotechnology are making this mission a reality and redefining how modern physicians and scientists identify, assess and combat threats to health and wellness…

“One company that is at the forefront of the new medicine arena is GATC Health, a pioneering technology company that is on a mission to leverage individualized genetic data to help predict risks and treatment outcomes and provide precision medicine that is tailored to each patient’s unique needs.”

You can read the full article here. (https://www.healthcaretechoutlook.com/magazines/October2021/Precision_Medicine/?digitalmagazine#page=20)

Healthcare Tech Outlook is an online and print publication offering a learn-from-peer approach to the healthcare arena, offering technology advice to enhance both the overall healthcare landscape and assist individual care providers, from general practitioners and specialists to post-acute care organizations.



About GATC Health



GATC Health is a pioneering technology company using whole genome analysis and disruptive multiomics-based artificial intelligence to revolutionize disease detection and drug discovery. GATC’s patented technologies deliver enormous reductions in risk, time and costs for its partners and customers. GATC Health’s innovations accelerate the healthcare’s transition to individualized medicine.

Disclaimer



The information set forth herein is presented for informational purposes only and should not be deemed an offer to sell securities.  This presentation contains information which the Company believes to be correct, including certain financial information and projections, but the Company does not guarantee as to the accuracy or completeness of such information.  The Company reserves the right to modify or amend the information contained herein.